Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Benralizumab in Uncontrolled Asthma (SIROCCO)
NCT01928771Phase 3Completed
- Sponsor
- AstraZeneca
- Start
- Sep 2013
- Primary completion
- Apr 2016
- Modality
- Monoclonal Antibodies
- Countries
- 17
01
Overview
A Phase 3 trial of benralizumab in asthma, sponsored by AstraZeneca. Started Sep 2013; status: completed.
02
Drugs
benralizumab
03
Conditions
asthma
Beyond the preview
Go deeper on NCT01928771.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01928771.